Related Experiment Video
Updated: May 2, 2026

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
Liver myofibroblasts up-regulate monocyte CD163 expression via PGE2 during hepatitis B induced liver failure
Min Zhang, Yinong Ye, Fenglan Wang
1Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, No 600 Tianhe Road, Guangzhou 510630, Guangdong Province, People's Republic of China. ytchong2005@126.com.
Background:
Although patients with liver failure exhibit a generalized inflammatory-imbalance status, substantial evidence indicates that this immunosuppressive or anti-inflammatory state may be deleterious. Increased expression of CD163 (known to be involved in several anti-inflammatory functions of the immune system) in patients with liver failure is significantly correlated with a fatal outcome. However, little is known of the regulatory mechanisms that influence the expression of CD163.
Methods:
We assessed the expression of CD163 on monocytes from both circulating cells and the liver tissues of patients with hepatitis B induced liver failure using flow cytometry and isolated the myofibroblasts from diseased livers. The ability of human liver myofibroblasts to regulate CD163 expression on monocytes was studied in vitro.
Results:
We showed that CD163⁺ monocytes were enriched primarily in diseased livers and that they were associated with liver myofibroblasts in the same area. Accordingly, liver myofibroblasts were significantly superior to normal skin fibroblasts in inducing the expression of CD163 on monocytes in vitro. Moreover, we found that liver myofibroblasts triggered the activation of monocytes by secreting PGE2. Inhibition of PGE2 production in liver myofibroblasts using NS-398 markedly reduced CD163 expression in vitro.
Conclusion:
These results suggest that liver myofibroblasts play a direct role in regulating the expression of CD163 on monocytes in human liver tissues and thereby may regulate monocyte function during hepatitis B induced liver failure.
Insights
Liver myofibroblasts promote CD163 expression on monocytes in liver failure. This suggests myofibroblasts regulate monocyte function, impacting patient outcomes in hepatitis B induced liver failure.
Area of Science:
- Immunology
- Hepatology
- Cell Biology
Background:
- Liver failure is associated with an inflammatory imbalance.
- Increased CD163 expression in liver failure correlates with poor outcomes.
- Regulatory mechanisms of CD163 expression remain unclear.
Purpose of the Study:
- Investigate the role of liver myofibroblasts in regulating CD163 expression on monocytes.
- Determine the mechanism by which liver myofibroblasts influence CD163 expression.
Main Methods:
- Assessed CD163 expression on monocytes from liver failure patients using flow cytometry.
- Isolated human liver myofibroblasts and co-cultured with monocytes in vitro.
- Measured prostaglandin E2 (PGE2) production and its effect on CD163 expression.
Main Results:
- CD163+ monocytes were enriched in diseased livers and associated with myofibroblasts.
- Liver myofibroblasts significantly induced CD163 expression on monocytes.
- Myofibroblast-secreted PGE2 activated monocytes and increased CD163 expression, which was inhibited by NS-398.
Conclusions:
- Liver myofibroblasts directly regulate CD163 expression on monocytes in hepatitis B induced liver failure.
- Myofibroblast-derived PGE2 is a key mediator in this regulation.
- These findings highlight a novel mechanism of monocyte function regulation in liver disease.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cirrhosis II: Pathophysiology
Cell Specific Gene Expression
Hepatitis
Gastritis II: Pathophysiology
Differentiation of Common Myeloid Progenitor Cells

